Skip to content

Author

Ke Xiong

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Key genetic biomarkers and therapeutic potential in multiple sclerosis: Insights from integrated bioinformatics and mendelian randomization.

This study integrates transcriptomic, genetic-causal, immunological, and structural analyses to prioritize STAT6 as a potentially druggable MS-associated target and strengthen the computational plausibility of STAT6-ligand interactions.

Zhongbo Xu, Ke Xiong, Dan Zhao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.